<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
VRTX
Vertex Pharmaceuticals
$
()


  • Vertex Pharmaceuticals announces advancements in suzetrigine pain program

    Today - 08:30am
  • Novartis reports results from interim analysis of Phase 3 APPLAUSE-IgAN study

    4/15/2024 - 14:05pm
  • Biotech Alert: Searches spiking for these stocks today

    4/12/2024 - 11:08am
  • Alpine Immune Sciences just downgraded at Leerink, here's why

    4/11/2024 - 19:48pm
  • What You Missed On Wall Street On Thursday

    4/11/2024 - 16:23pm
  • What You Missed On Wall Street This Morning

    4/11/2024 - 12:02pm
  • Analyst thinks this drugmaker could be next after Alpine's $4.9B acquisition

    4/11/2024 - 10:49am
  • DoorDash upgraded, Airbnb downgraded: Wall Street's top analyst calls

    4/11/2024 - 09:40am
  • Vertex Pharmaceuticals price target raised by $5 at H.C. Wainwright, here's why

    4/11/2024 - 08:43am
  • Evercore expects Vera Therapeutics to trade up on Alpine acquisition news

    4/11/2024 - 06:34am
  • Vertex Pharmaceuticals just upgraded at Evercore ISI, here's why

    4/11/2024 - 06:26am
  • Drugmakers look to alternative suppliers after draft U.S. legislation, FT says

    4/11/2024 - 06:23am
  • Alpine Immune downgraded to Sector Perform from Outperform at RBC Capital

    4/11/2024 - 05:10am
  • Fly Intel: After-Hours Movers

    4/10/2024 - 17:35pm
  • Vertex to acquire Alpine Immune Sciences for $65 per share

    4/10/2024 - 16:02pm
dynamic_feed Breaking News